Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma
Status:
Unknown status
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
This is a pilot study of concomitant radiotherapy and thalidomide for patients with locally
advanced HCC.Besides toxicity and efficacy, mechanistic studies including dynamic contrast
enhanced MRI and serum cytokines will be evaluated.